NL-OMON43451已完成不适用
Distractibility in ADHD associated with reduced ability to modulate alpha band oscillations in attentional tasks - SHARK 2.0
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •For both groups inclusion criteria will be: (1) Age between 8 and 12 years. (2) Enrolled in primary (not secondary) school. (3) Estimated IQ above 80.
- •For the ADHD-group an additional inclusion criterion will be: (1) a clinical diagnosis of ADHD according to the criteria of the DSM-V (see *Study procedures* for detailed description). (2) Scored in the clinical range on the ADHD DSM-IV rating scale, completed by parents. (3) Pharmacological treatment with Methylphenidate (either long- or short-acting formulations), which started at least 3 months before the inclusion in the study.
排除标准
- •For both groups exclusion criteria will be: (1) (Co-morbid) psychiatric disorder (major depression, bipolar disorder, psychotic disorder, chronically motor tic disorder or Gilles de la Tourette, Conduct disorder, autism spectrum disorder, eating disorder, anxiety disorder). (2) Neurological disorders (e.g. epilepsy) currently or in the past. (3) Cardiovascular disease currently or in the past. (4) Serious motor or perceptual handicap. (5) Standard MRI Exclusion criteria according to DCCN regulations (see attached pdf in cmo application section: K6: *MR algemene informatie*).
研究者
相似试验
已完成
1 期
erofeeback Training (NFT) of ADHD child at homeADHDADHD hyperactiveD046650JPRN-jRCT1030220201Tazaki Miyako8
已完成
2 期
Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)ADHDNCT01124708Targacept Inc.134
招募中
2 期
Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels.Attention Deficit Hyperactivity DisorderNL-OMON37512niversitair Medisch Centrum Sint Radboud
已完成
不适用
Neural Mechanisms of Attention Lapses in Adult ADHDAttention Deficit DisorderHyperactivity DisorderNCT03948607University Hospital, Strasbourg, France63
进行中（未招募）
不适用
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHDEUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30